开盘$101.54
昨收$104.84
当日区间$100.80 – $103.07
成交量7.45M
市值$130.22B
市盈率（TTM）25.1
股息率2.80%
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例91.3%+4.23 个百分点，较上季度
持仓机构数2,590+48 ，较上季度
内部人近期交易25次买入 / 20次卖出净买入
空头持仓比例10.87% 占流通股回补天数 2.9 · 截至 15 Oct 2026
卖空成交量占比14.4%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$95.83M（7个净流入日，13个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有27.2%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从1.41%升至10.87%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +8,233,285 | 1.1% |
| SG Americas Securities, LLC | Private Company | 2026/Q3 | +6,500,749 | 0.5% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +4,391,136 | 0.4% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +3,902,806 | 1.4% |
| First Eagle Investment Management, LLC | Mutual Fund | 2026/Q3 | +3,739,288 | 1.1% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +3,725,897 | 0.4% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +3,502,166 | 0.4% |
| Barclays PLC | Public Company | 2026/Q3 | +3,383,299 | 0.5% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +3,175,109 | 0.3% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +3,167,741 | 0.3% |
| Qube Research & Technologies Ltd | Mutual Fund | 2026/Q3 | +2,693,680 | 0.2% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +2,635,279 | 0.3% |
| Federated Hermes, Inc. | Mutual Fund | 2026/Q3 | +2,486,265 | 0.4% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +2,242,468 | 0.3% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +2,177,702 | 0.2% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 14 Oct 2026 | Kevin Lofton | Independent Director | Other Disposition | -182 | – | 7,866 |
| 14 Oct 2026 | Geoffrey Martha | Chairperson & CEO | Automatic Disposition | -50,000 | $95.00 | 158,820 |
| 14 Oct 2026 | Geoffrey Martha | Chairperson & CEO | Intent to Sell (Form 144) | -50,000 | $95.00 | – |
| 14 Oct 2026 | Michael Marinaro | President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops | Automatic Disposition | -10,420 | $96.00 | 25,273 |
| 14 Oct 2026 | Michael Marinaro | Executive VP and President of Medical Surgical Portfolio & Americas | Intent to Sell (Form 144) | -10,420 | $96.00 | – |
| 15 Sep 2026 | Harry Kiil | Executive VP & President of Cardiovascular Portfolio | Open Market Disposition | -1,483 | $93.65 | 7,767 |
| 14 Sep 2026 | Denise Blomquist | VP, Global Controller & Chief Accounting Officer | Other Disposition | -600 | – | 6,542 |
| 19 Aug 2026 | Michael Marinaro | President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops | Sale to Issuer | -1,084 | $92.30 | 35,693 |
| 2 Aug 2026 | Geoffrey Martha | Chairperson & CEO | Other Acquisition | +41,533 | – | 119,046 |
| 2 Aug 2026 | Geoffrey Martha | Chairperson & CEO | Other Derivative Acquisition | +103,831 | – | 103,831 |
| 2 Aug 2026 | Geoffrey Martha | Chairperson & CEO | Other Derivative Acquisition | +568,152 | $86.68 | 273,150 |
| 2 Aug 2026 | Thierry Pieton | Chief Financial Officer | Other Acquisition | +11,537 | – | 42,153 |
| 2 Aug 2026 | Thierry Pieton | Chief Financial Officer | Other Derivative Acquisition | +28,842 | – | 28,842 |
| 2 Aug 2026 | Thierry Pieton | Chief Financial Officer | Other Derivative Acquisition | +81,945 | $86.68 | 81,945 |
| 2 Aug 2026 | Harry Kiil | Executive VP & President of Cardiovascular Portfolio | Other Acquisition | +9,230 | – | 34,419 |
| 2 Aug 2026 | Harry Kiil | Executive VP & President of Cardiovascular Portfolio | Other Derivative Acquisition | +23,074 | – | 23,074 |
| 2 Aug 2026 | Harry Kiil | Executive VP & President of Cardiovascular Portfolio | Other Derivative Acquisition | +65,556 | $86.68 | 65,556 |
| 2 Aug 2026 | Michael Marinaro | President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops | Other Acquisition | +57,107 | – | 88,690 |
| 2 Aug 2026 | Michael Marinaro | President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops | Other Derivative Acquisition | +27,400 | – | 27,400 |
| 2 Aug 2026 | Michael Marinaro | President and President of Medical Surgical Portfolio, Americas & Global Commercial Ops | Other Derivative Acquisition | +77,848 | $86.68 | 77,848 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 139,004,337 | 10.9% | 2.9 |
| 30 Sep 2026 | 39,974,230 | 3.1% | 2.7 |
| 15 Sep 2026 | 17,229,743 | 1.3% | 2.0 |
| 31 Aug 2026 | 12,134,511 | 0.9% | 1.7 |
| 14 Aug 2026 | 14,350,429 | 1.1% | 2.3 |
| 31 Jul 2026 | 18,120,230 | 1.4% | 2.4 |
暂无评论——快来第一个聊聊 MDT。
登录后参与讨论。